Background: Acute lymphoblastic leukemia (ALL) is presented with different immunophenotypic pattern.
Objective: The purpose of the study was to evaluate the immunophenotypic pattern of ALL and also, to recognize the frequency of different ALL subtypes and treatment outcome after induction remission therapy.
Methodology: This prospective study was conducted in the Department of Paediatric Hematology and Oncology at Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh from June 2017 to July 2018 for a period of one year. Newly diagnosed admitted cases of ALL aged 1 to 17.9 years were included. Immunophenotyping from aspirate marrow samples were done in a special hematology laboratory. Patients were monitored during induction remission period with physical examination and required investigations.
Result: Among 87 analyzed patients, 81 patients (93.1%) were B-cell ALL and 6 patients (6.9%) were T-cell ALL. After completion of induction remission therapy 61 patients had undergone complete remission and among them B cell ALL were 56(69.1%) and T cell were 5(83.3%) (P=0.464). None of the patient had partial response or induction failure. Complication were developed in 53(60.91%) patients during induction therapy. Most common cause of death was septicemia (22/26). Death was more in patients who had total WBC count >50X109/L (p=0.017) and received regimen B (p=0.031).
Conclusion: B cell ALL was more common and most of the patients had undergone complete remission after induction remission therapy.
Journal of Current and Advance Medical Research, January 2021;8(1):59-64
if a clot occurs when checking platelets using EDTA anti-coagulant. The purpose of this study was to determine differences in platelet count results using EDTA and Na Citrat anticoagulants. This research was conducted at Mitra Kemayoran Hospital in April-June 2018. The samples in this study were all patients who performed platelet count examination at Mitra Kemayoran Hospital in April-June 2018. The data in this study were carried out by examining the platelet count using anticoagulants EDTA and Na Citrat. The data in this study were analyzed using Normality Test and test Test. The results at this time obtained the p-value of the examination results of 0.222 from these results can be censored if there are no correct results from examining the platelet count using EDTA and Na Citrat anticoagulants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.